| P50 | author | Philip J Wiffen | Q28036553 |
| | Robert Andrew Moore | Q56192531 |
| | Ian Gilron | Q87690248 |
| | Luis Enrique Chaparro | Q117285415 |
| P2860 | cites work | The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey | Q21710682 |
| | Single dose oral analgesics for acute postoperative pain in adults | Q24234549 |
| | Neuropathic pain: a practical guide for the clinician | Q24553796 |
| | Intravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol [ISRCTN33042138] | Q24800818 |
| | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 |
| | Herpes zoster and post-herpetic neuralgia--a clinical trial of aspirin in chloroform for anodyne | Q28180923 |
| | Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain | Q28373985 |
| | Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study | Q28750315 |
| | Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects | Q29619558 |
| | Meta-analysis in clinical research | Q29620885 |
| | Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study | Q31454905 |
| | Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice | Q33566361 |
| | Opioids for chronic noncancer pain: a new Canadian practice guideline | Q33900792 |
| | EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision | Q34110857 |
| | The evidence for pharmacological treatment of neuropathic pain | Q34130946 |
| | Morphine, gabapentin, or their combination for neuropathic pain. | Q34407545 |
| | An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy | Q34418375 |
| | A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: the aspirin/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trial | Q34424661 |
| | A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol | Q34561595 |
| | A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. | Q34619839 |
| | Prevalence of chronic pain with neuropathic characteristics in the general population. | Q34691911 |
| | Neuropathic pain: a clinical perspective | Q34995660 |
| | Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. | Q35080568 |
| | Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain | Q35987634 |
| | Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds | Q46694801 |
| | Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia | Q46870593 |
| | Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy | Q48479143 |
| | Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale | Q48823789 |
| | Nerve root sleeve injections in patients with failed back surgery syndrome: a comparison of three solutions | Q49170510 |
| | Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. | Q51583296 |
| | Peripheral streptomycin/lidocaine injections versus lidocaine alone in the treatment of idiopathic trigeminal neuralgia. A double blind controlled trial. | Q51729555 |
| | Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. | Q53566001 |
| | Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. | Q53933325 |
| | A new definition of neuropathic pain | Q57987223 |
| | Clinical trial of amitriptyline and fluphenazine in diabetic peripheral neuropathy | Q67295314 |
| | A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy | Q68859436 |
| | [Treatment of chronic painful conditions with a diazethylthiamine (fat-soluble vitamin B 1) combination preparation] | Q70090529 |
| | Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up | Q70351578 |
| | [Differential combined drug therapy of phantom pain syndrome after amputation of extremity] | Q71924923 |
| | An Open and Double-Blind Cross-Over Study on the Efficacy of Clomipramine (Anafranil®) in Patients with Painful Mono- and Polyneuropathies | Q72534452 |
| | Therapy of lumbar sciatica. A comparative clinical study of a corticoid-free monosubstance and a corticoid-containing combination drug | Q72756699 |
| | Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain | Q74372640 |
| | Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy | Q74535016 |
| | A conservative method of testing whether combination analgesics produce additive or synergistic effects using evidence from acute pain and migraine | Q83586478 |
| | Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial | Q84741622 |
| | Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction | Q95815497 |
| | Transcutaneous electrostimulation: emerging treatment for diabetic neuropathic pain | Q39416314 |
| | The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury | Q39424415 |
| | Intrathecal methylprednisolone for intractable postherpetic neuralgia | Q39424571 |
| | Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain | Q39427591 |
| | Ineffectiveness of dextromethorphan in cancer pain | Q39443090 |
| | Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. | Q39443508 |
| | A double-blind randomised comparison of the effects of epidural clonidine, lignocaine and the combination of clonidine and lignocaine in patients with chronic pain | Q39467718 |
| | A controlled study of caudal epidural injections of triamcinolone plus procaine for the management of intractable sciatica | Q39509454 |
| | Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study | Q39546487 |
| | Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia | Q39583843 |
| | The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction? | Q40331836 |
| | Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale | Q40678235 |
| | The addition of GTN to capsaicin cream reduces the discomfort associated with application of capsaicin alone. A volunteer study | Q42537865 |
| | Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes | Q42667999 |
| | Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment | Q42966636 |
| | Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial. | Q43056149 |
| | Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study | Q43134120 |
| | Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine | Q43136215 |
| | A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain | Q43195003 |
| | Comparative study of clinical efficacy with amitriptyline, pregabalin, and amitriptyline plus pregabalin combination in postherpetic neuralgia | Q43198379 |
| | Vitamin B complex (milgamma) in the treatment of vertebrogenic lumbosacral radiculopathy | Q43206640 |
| | A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS study | Q43260743 |
| | Periradicular infiltration for sciatica: a randomized controlled trial | Q43598011 |
| | Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. | Q43952866 |
| | Influence of early high-dose steroid treatment on Bell's palsy evolution | Q44187879 |
| | A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain | Q44301961 |
| | An Open‐Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy | Q44544970 |
| | Efficacy of transdermal nitroglycerin combined with etodolac for the treatment of chronic post-thoracotomy pain: an open-label prospective clinical trial | Q44810521 |
| | Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group | Q44978609 |
| | Effect of periradicular methylprednisolone on spontaneous resorption of intervertebral disc herniations | Q45000614 |
| | NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia | Q45048454 |
| | Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study | Q46126054 |
| | Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study | Q46192686 |
| | Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. | Q46200483 |
| | Management of neuropathic pain with methylprednisolone at the site of nerve injury. | Q46333573 |
| | Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial | Q46570904 |
| | Core outcome measures for chronic pain clinical trials: IMMPACT recommendations | Q35994723 |
| | Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study | Q36055428 |
| | How to appraise the effectiveness of treatment | Q36097002 |
| | Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources | Q36288700 |
| | Combination pharmacotherapy for neuropathic pain: current evidence and future directions | Q36307880 |
| | Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy | Q36649993 |
| | Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. | Q37420430 |
| | Determination of pain and response to methylprednisolone in Guillain-Barré syndrome | Q37424369 |
| | Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain | Q37441760 |
| | Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations | Q37703919 |
| | "Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews | Q37772314 |
| | A critical review of the American Pain Society clinical practice guidelines for interventional techniques: part 2. Therapeutic interventions. | Q37774566 |
| | Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review | Q37776596 |
| | Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses | Q37953039 |
| | Combination therapy for neuropathic pain: a review of current evidence | Q37963569 |
| | Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study | Q39252235 |
| | Effect of addition of epidural ketamine to steroid in lumbar radiculitis: one-year follow-up. | Q39259148 |
| | Multimodal approach to therapy-related neuropathic pain in breast cancer. | Q39264388 |
| | Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy. | Q39281191 |
| | NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. | Q39283066 |
| | Intrathecal clonidine and baclofen enhance the pain-relieving effect of spinal cord stimulation: a comparative placebo-controlled, randomized trial. | Q39284304 |
| | Efficacy of intrathecal midazolam with or without epidural methylprednisolone for management of post-herpetic neuralgia involving lumbosacral dermatomes. | Q39285540 |
| | Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study | Q39286848 |
| | A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin | Q39294713 |
| | Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial | Q39297779 |
| | Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. | Q39302959 |
| | Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients | Q39323940 |
| | Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone | Q39325281 |
| | Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial | Q39333487 |
| | The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia. | Q39358988 |
| | MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance | Q39366703 |
| | Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain | Q39373636 |
| | A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain | Q39390666 |
| | Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. | Q39403778 |
| P433 | issue | 7 | |
| P921 | main subject | neuropathic pain | Q2798704 |
| | pharmacotherapy | Q701216 |
| P304 | page(s) | CD008943 | |
| P577 | publication date | 2012-07-11 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Combination pharmacotherapy for the treatment of neuropathic pain in adults | |